BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel
PDL BioPharma, Inc. (NQ: PDLI)
8.410 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 8:10 PM EDT, Apr 17, 2014  /  Add to My Watchlist      
(PDLI) Community Analysis from
April 20, 2014
(Jutia Group, 11/29/13)
[at Forbes] - Looking at the universe of stocks we cover at Dividend Channel, on 12/3/13, Home Depot Inc (NYSE: HD), PDL BioPharma Inc...(read more)
(market folly, 2/10/12)
Seth Klarman 's hedge fund firm Baupost Group filed an amended 13G with the SEC regarding their position in PDL BioPharma (PDLI). The new filing shows Baupost has a 2.15% ownership stake in...(read more)
(Morningpick, 11/2/11)
My morning pick is Pdl Biopharma PDLI. How does this company make money? PDL BioPharma (NASDAQ: PDLI) is a biotech company with a patented process to create humanized antibodies. PDL engages in the...(read more)
PDL BioPharma (PDLI) Company Overview

PDL BioPharma (Nasdaq:PDLI) is a biotech company with a patented process to create humanized antibodies. Antibodies are an increasingly important tool in the arsenal of advanced "targeted therapies" that pharmaceutical companies are rolling out to combat diseases such as cancer. Traditional Fcancer drugs kill cancer cells, but also healthy cells as well, making them extremely toxic and limiting the doses that can be given to patients. Targeted therapies, however, impact only cancerous cells, can be given in higher doses, and are often more effective than traditional chemotherapy regimens. Examples include Genetech's Avastin, Herceptin, and Lucentis and Medimmune's Synagis, which are all produced using PDLI's antibody technology.

It is relatively easy for a biotech company to make a mouse or chicken antibody[1]. However, these animal antibodies can cause severe histemic (allergic) reactions when used in humans. As a result, humananized antibodies, which are trickier to produce, are preferred. PDL licences the technology to produce humanized antibodies to other pharmaceutical and biotech companies in exchange for royalty payments and often a cut of the drug's future revenue stream if it proves successful.[2]

(Read more at Wikinvest )

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here